Arovella Therapeutics Limited (ASX: ALA)
Sector: Health Care
Market cap: A$64M (as of 2 Nov 2026)
A biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell platform for cancer treatment.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 5 Mar 2025 | BNP PARIBAS NOMS PTY LTD | Entry | ?% → 9.35% | Filing ↗ |
| 17 Sept 2024 | Biotech Capital Management Pty Ltd as investment manager for the Merchant Biotech Fund (and related entities and associates as described below) | Entry | ?% → 10.348% | Filing ↗ |
| 17 Sept 2024 | Merchant Funds Management Pty Ltd (ABN 32 154 493 277) as manager of the Merchant Opportunities Fund (ARSN 111 456 387) and Merchant Group Pty Ltd (ABN 56 154 832 237) | Decrease | 11.360% → 5.750% | Filing ↗ |
| 21 June 2023 | Richard John Mann, Mann Beef Pty Ltd, The Lochwall Super Fund and Yasmin Marie Dennis Mann | Entry | ?% → 6.48% | Filing ↗ |
| 22 May 2023 | Merchant Funds Management Pty Ltd (ABN 92 154 493 277) as manager of the Merchant Biotech Fund (ARSN 654 495 468) and Merchant Group Pty Ltd (ABN 56 154 832 237) | Increase | 11.360% → 11.360% | Filing ↗ |
Director trades — on-market
| Date | Director | Trade | Source |
|---|---|---|---|
| 9 June 2026 | David John Williams | Bought 200,000 Ordinary Shares | Filing ↗ |
| 28 Mar 2024 | Dr Thomas George Duthy | Bought 103,000 | Filing ↗ |
| 28 Mar 2024 | Gary Jonathan Phillips | Bought 66,666 Ordinary Shares | Filing ↗ |
| 27 Mar 2024 | Dr Michael Baker | Bought 220,000 Ordinary Shares | Filing ↗ |
| 15 Dec 2021 | Paul Hopper | Bought 1,000,000 ordinary shares | Filing ↗ |
Cash and runway
Ask about ALA in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has ALA raised money in the last year, and at what discount?
- What was ALA's latest cash position and runway?
Loading ALA…